Tech Mogul Clones Himself for Anti-Aging Research

Tech entrepreneur Bryan Johnson has revealed a controversial new phase in his pursuit of radical longevity: the creation of a clone of himself. Johnson, 48, announced via social media that 'baby-Bryan,' a clone created from his own cells, exists in a Petri dish. This clone is intended to act as a medical resource for Johnson, facilitating blood transfusions, testing novel therapies, and potentially cultivating organs for future transplantation.

The technology behind this development involves restoring Johnson's blood cells to a state resembling embryonic cells. This process is designed to reverse the aging process and could offer pathways to repair the body. Johnson stated that this technology already has clinical trial applications for conditions like Parkinson's disease, demonstrating its potential beyond anti-aging.

Johnson recently disclosed a diagnosis of Autoimmune Gastritis, a condition for which there is no known cure. He expressed his intent to tackle this health challenge using a combination of intensive medical monitoring and experimental treatments. The public reaction to his diagnosis and his ongoing mission to defy aging has been mixed, with Johnson noting a deeper societal discomfort with challenging the inevitability of death.